ORIC Pharmaceuticals Azioni (NASDAQ: ORIC)

ORIC Pharmaceuticals

ORIC PHARMACEUTICALS INC

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Oric Pharmaceuticals, Inc. - Common Stock

ORIC Pharmaceuticals Inc

Orica Ltd

News

Health Care

Press Releases

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences

ORIC® Pharmaceuticals Announces Potentially Best-In-Class Preliminary Efficacy and Safety Data from Ongoing Phase 1b Trial of ORIC-944 in Combination with AR Inhibitors for the Treatment of Patients with mCRPC

Financing

ORIC® Pharmaceuticals Announces $125 Million Private Placement Financing

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Earnings

ORIC® Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Updates

Management

ORIC® Pharmaceuticals Expands Leadership Team with the Appointment of Kevin Brodbeck as Chief Technical Officer

ORIC

Ardelyx

Aurinia Pharmaceuticals Inc - Common Shares

Aurinia Pharmaceuticals

BioCryst Pharmaceuticals, Inc. - Common Stock

BioCryst Pharma

CureVac

Dianthus Therapeutics, Inc. - Common Stock

Dianthus Therapeutics

Dynavax Technologies Corporation - Common Stock

Dynavax Technologies

Immunome

Immatics

Janux Therapeutics

MannKind

Nanobiotix

Anbio Biotechnology - Class A Ordinary Shares

Anbio Biotechnology

Novavax

Oruka Therapeutics

Precigen

Relay Therapeutics

Sana Biotechnology

Sionna Therapeutics

Syndax Pharmaceuticals, Inc. - Common Stock

Syndax Pharmaceuticals

Tourmaline Bio

Taysha Gene Therapies, Inc. - Common Stock

Taysha Gene Therapies

Upstream Bio

Xencor

Zenas BioPharma

Zymeworks

Guggenheim

JP Morgan

HC Wainwright & Co.

Ladenburg Thalmann

Comments

ORIC Pharmaceuticals

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO